NUCB2 and metabolic dysfunction-associated steatotic liver disease: In a mouse model of NAFLD, resveratrol reverted hepatic disfunction associated with nesfatin-1 and glicolipidic metabolism, as showed by the blood levels of transaminases, total bilirubin, total cholesterol, LDL-cholesterol, glycemia, insulinemia, and nesfatin-1.